10.1.3 Drugs that suppress the rheumatic disease process (specialist treatments)

• Disease Modifying Anti-Rheumatic Drugs (DMARDs) on the AMBER list are initiated by specialists in secondary care and can be prescribed by GPs under a shared care arrangement. Refer to the Red Amber List for further details including shared care guidelines as appropriate. Note shared care guidelines are updated regularly and paper copies should not be relied on.
• Biological therapies and Janus kinase (JAK) inhibitors are RED list treatments for specialist use only.